HAb18 Fab was prepared successfully, which lays a foundation for its further application to diagnosis and therapy of human hepatocellular carcinoma.

• 成功地构建了抗人肝癌小分子Fab抗体,为其进一步在肝癌诊断与治疗中的应用奠定了基础。